1. Home
  2. Live Updates
  3. Ovid Therapeutics (NASDAQ:OVID) Price Target Lowered to $3.5

Ovid Therapeutics (NASDAQ:OVID) Price Target Lowered to $3.5

Ovid Therapeutics (NASDAQ:OVID) Price Target Lowered to $3.50 at Citigroup

Ovid Therapeutics (NASDAQ:OVID) Price Target Lowered to $3.50 at Citigroup

themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Jeremym Levin , , Connor Clark Lunn Investment Management Ltd , Citigroup , Ovid Therapeutics Inc , Wealth Management , Ovid Therapeutics , Get Free Report , Therapeutics Stock Down , Point Capital , Connor Clark , Lunn Investment Management , Therapeutics Inc , Ovid Therapeutics Daily ,